Grupo para la caracterización molecular de las neoplasias hematológicas
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Investigaciones Cardiovasculares Carlos III (2)
2021
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
2016
-
Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
Blood, Vol. 128, Núm. 18, pp. 2241-2252